Last reviewed · How we verify
NCT05525442
Factors Affecting The Recurrence Of Acute Cholecystitis After Treatment With Percutaneous Cholecystostomy
trial testing percutaneous cholecystostomy in Acute Cholecystitis in 102 participants. Completed in 1 January 2022.
1 January 2021
Quick facts
| Lead sponsor | Tepecik Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 102 |
| Start date | 1 January 2015 |
| Primary completion | 1 January 2021 |
| Estimated completion | 1 January 2022 |
Drugs / interventions tested
- percutaneous cholecystostomy
Conditions studied
- Acute Cholecystitis — all drugs for Acute Cholecystitis →
- Percutaneous Cholecystostomy — all drugs for Percutaneous Cholecystostomy →
- Recurrence — all drugs for Recurrence →
Sponsor
Tepecik Training and Research Hospital
Who can join
18 and older, any sex, with Acute Cholecystitis or Percutaneous Cholecystostomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Percutaneous cholecystostomy is used to reduce the complications and mortality associated with surgery in patients with high surgical risk in acute cholecystitis. Although this method generally acts as a bridge treatment for interval cholecystectomy in patients, interval cholecystectomy is not performed in every patient after percutaneous cholecystostomy. The aim of this study was to determine the recurrence rate of patients who did not have interval cholecystectomy after treatment with percutaneous cholecystostomy and to investigate the factors that may affect the recurrence.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Factors affecting the recurrence of acute cholecystitis after treatment with percutaneous cholecystostomy.
Tuncer K, Kilinc Tuncer G, Çalık B. · · 2023 · cited 8× · PMID 37231394 · DOI 10.1186/s12893-023-02042-2
Verify or expand the search:
- PubMed search for NCT05525442
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of percutaneous cholecystostomy
Trials testing the same drug.
- NCT04979936 — Early Laparoscopic Cholecystectomy Versus Percutaneous Cholecystostomy in Grade II Acute Cholecystitis Guidelines · NA · completed
Other recruiting trials for Acute Cholecystitis
Currently open trials in the same condition.
- NCT07161960 — Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE) · NA · recruiting
- NCT06967597 — Conservative Versus Proactive Management of Acute Cholecystitis After EUS-guided Transmural Gallbladder Drainage: FUGITI · NA · recruiting
- NCT07006298 — One-year Outcomes by Index Treatment in Elderly Patients With Acute Cholecystitis · recruiting
- NCT06287112 — Prevention of Acute Cholecystitis With ETGBD · NA · recruiting
- NCT05732480 — Influence of Gut Microbiome in Gallstone Disease · recruiting
Other Tepecik Training and Research Hospital trials
Trials by the same sponsor.
- NCT07533916 — ICU Environmental Noise and Healthcare Workers · completed
- NCT07526467 — Video-EEG Semiological Patterns in PNES · completed
- NCT07299708 — Effects of Sleep Quality, Anxiety, and Digital Behavior on Labor Progression in Term Primiparous Women: A Prospective Ob · completed
- NCT06563830 — Prevent Medical Device-Related Pressure Injury · NA · not yet recruiting
- NCT05946291 — Simulation Applications on the Level of Pressure Injury Knowledge and Evaluation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05525442 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tepecik Training and Research Hospital
- Last refreshed: 1 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05525442.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing